Relay Therapeutics, Inc. (RLAY)
18.87
-0.02
(-0.11%)
USD |
NASDAQ |
Sep 11, 16:00
18.86
-0.01
(-0.05%)
After-Hours: 20:00
Relay Therapeutics Profit Margin (Quarterly) : -23.92K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.92K% |
| March 31, 2026 | -2.44K% |
| December 31, 2025 | -784.1% |
| September 30, 2025 | |
| June 30, 2025 | -10.40K% |
| March 31, 2025 | -1.00K% |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | -813.3% |
| December 31, 2023 | |
| September 30, 2023 | -260.8% |
| Date | Value |
|---|---|
| June 30, 2023 | -82.78K% |
| March 31, 2023 | -41.70K% |
| December 31, 2022 | -26.68K% |
| September 30, 2022 | -24.47K% |
| June 30, 2022 | -21.04K% |
| March 31, 2022 | -14.81K% |
| December 31, 2021 | -11.90K% |
| September 30, 2021 | -9.13K% |
| June 30, 2021 | -22.91K% |
| March 31, 2021 | -4.43K% |
| December 31, 2020 | 42.68% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| TG Therapeutics, Inc. | 3.24% |
| Karyopharm Therapeutics, Inc. | -200.5% |
| Krystal Biotech, Inc. | 45.94% |
| Akebia Therapeutics, Inc. | -18.13% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -42.41% |
| Return on Assets | -38.79% |
| Return on Invested Capital | -40.46% |
| Gross Profit Margin (Quarterly) | -2.86% |
| Operating Margin (Quarterly) | -25.95K% |
| Return on Net Operating Assets | -497.1% |